Inactive Instrument

Press Releases Lexaria Corp Other OTC

Equities

US52886N2080

End-of-day quote Other OTC Other stock markets
- ^USD	-

Apr. 16	Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study	MT
Apr. 16	Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance	Apr. 30	AQ
Lexaria Bioscience : Corporate Highlight Sheet	Apr. 11	PU
Lexaria Awarded New Patents	Apr. 02	AQ
Lexaria Bioscience : Amendment of a Material Definitive Agreement - Form 8-K	Mar. 21	PU
Lexaria to Present at The LD Micro Invitational XIV	Mar. 21	NE
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer	Mar. 14	AQ
Lexaria Bioscience : Corporate Highlight Sheet	Mar. 08	PU
Lexaria Awards Contract For Next GLP-1 Human Pilot Study	Mar. 07	AQ
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1	Mar. 05	AQ
7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study	Mar. 04	AQ
Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial	Mar. 01	AQ
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	Feb. 15	AQ
Lexaria Submits Investigational New Drug Application	Jan. 30	AQ
Lexaria Releases Annual Letter from the CEO	Jan. 24	AQ
Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program	Jan. 16	AQ
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream	Jan. 11	AQ
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform	Jan. 09	AQ
Lexaria's Patented Technology Improved the Oral Performance of the Rybelsus-Branded GLP-1 drug Semaglutide	Jan. 04	AQ
Lexaria Bioscience : Corporate Highlight Sheet	Dec. 08	PU
Lexaria's Investigational New Drug Application Filing Update	Dec. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Lexaria Corp Other OTC

Equities

US52886N2080

Press Releases

Filters